Answers are grounded in this paper and cite their sources.
The overall frequency of the BRCA germline mutations was 14.17% in patients with high risk of breast/ovarian cancer. We identified recurrent mutations as the c.1310_1313 delAAGA in BRCA2 gene and the c.5030_5033 delCTAA in BRCA1 gene that were found in 4% and 20% of familial BC and OC respectively. Our data will contribute in the implementation of genetic counseling and testing for families with high-risk of BC and/or OC.
No takes yet. Share an insight, caveat, or question.
Ayed‐Guerfali et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: